IFB-088 has been granted Orphan-Drug Designation from the FDA in the treatment of Amyotrophic Lateral Sclerosis (ALS). IFB-088 is a... View Article
Author Archives for Adeline Chauvigné
InFlectis BioScience granted Orphan Drug Designation for IFB-088 (icerguastat), a clinical stage treatment for Amyotrophic Lateral Sclerosis
18 May 2024IFB-088 has been granted Orphan-Drug Designation from the FDA in the treatment of Amyotrophic Lateral Sclerosis (ALS). IFB-088 is a... View Article
Promega Corporation and FUJIFILM Cellular Dynamics announce strategic collaboration to advance novel assay development
New licensing agreement will deliver luminescent reporter technology into iPSCs Promega Corporation (Promega), a leader in providing innovative solutions and technical... View Article
Promega Corporation and FUJIFILM Cellular Dynamics announce strategic collaboration to advance novel assay development
18 May 2024New licensing agreement will deliver luminescent reporter technology into iPSCs Promega Corporation (Promega), a leader in providing innovative solutions and technical... View Article
Pherecydes Pharma granted a new patent for its anti-Pseudomonas aeruginosa phages in Europe
Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the... View Article
Pherecydes Pharma granted a new patent for its anti-Pseudomonas aeruginosa phages in Europe
18 May 2024Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the... View Article
OSE Immunotherapeutics provides positive long term memory responses with CoVepiT, its T lymphocyte multi-target anti-COVID vaccine
Positive long term immunological results at 6 months in healthy volunteers with strong T cell memory responses against virus proteins.... View Article
OSE Immunotherapeutics provides positive long term memory responses with CoVepiT, its T lymphocyte multi-target anti-COVID vaccine
18 May 2024Positive long term immunological results at 6 months in healthy volunteers with strong T cell memory responses against virus proteins.... View Article
SEABELIFE RECEIVES CLOSE TO €1.4M DEEP TECH FINANCING FROM BPIFRANCE
Funds will enable SeaBeLife to develop pipeline of innovative molecules intended to block programmed cell death in cases of acute... View Article
SEABELIFE RECEIVES CLOSE TO €1.4M DEEP TECH FINANCING FROM BPIFRANCE
18 May 2024Funds will enable SeaBeLife to develop pipeline of innovative molecules intended to block programmed cell death in cases of acute... View Article
New member | Tacthys
Tacthys is a holding company created in 2013 and located on the Finistère. The group includes 3 subsidiaries that work... View Article
New member | Tacthys
18 May 2024Tacthys is a holding company created in 2013 and located on the Finistère. The group includes 3 subsidiaries that work... View Article
Valneva provides regulatory update on its COVID-19 vaccine candidate
Valneva , a specialty vaccine company, today provided an update on the regulatory review of its inactivated, COVID-19 vaccine candidate,... View Article
Valneva provides regulatory update on its COVID-19 vaccine candidate
18 May 2024Valneva , a specialty vaccine company, today provided an update on the regulatory review of its inactivated, COVID-19 vaccine candidate,... View Article
HTL announces its incubator’s equity investment in GelMEDIX, an early-stage biotech aiming at revolutionizing ocular and regenerative therapies
This partnership represents the first equity investment of an incubator created by HTL, pioneer and world leader in the development... View Article
HTL announces its incubator’s equity investment in GelMEDIX, an early-stage biotech aiming at revolutionizing ocular and regenerative therapies
18 May 2024This partnership represents the first equity investment of an incubator created by HTL, pioneer and world leader in the development... View Article
Pherecydes Pharma extends its intellectual property in China
Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announced the granting... View Article
Pherecydes Pharma extends its intellectual property in China
18 May 2024Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announced the granting... View Article
New member | ODPM
Founded in 2010, ODPM creates, develops and markets innovative and high performance solutions for personalized medicine in oncology. Its services are emanations of the... View Article
New member | ODPM
18 May 2024Founded in 2010, ODPM creates, develops and markets innovative and high performance solutions for personalized medicine in oncology. Its services are emanations of the... View Article